Victory Capital Management
LNAI

Victory Capital Management’s Lunai Bioworks LNAI Stock Holding History

Victory Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-129
Closed -$4.97K – 2526
2024
Q3 		$4.97K Sell
129
-42
-25% -$2.91K ﹤0.01% 2479
2024
Q2 		$23.9K Buy
171
+4
+2% +$545 ﹤0.01% 2419
2024
Q1 		$35.5K Buy
+167
New +$45K ﹤0.01% 2400

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Victory Capital Management's LNAI Position: Q4 2024 in Review

Victory Capital Management sold out of Lunai Bioworks (LNAI) in Q4 2024, closing a stake of 129 shares — an estimated $4.97K sold.

Victory Capital Management first reported a position in LNAI in Q1 2024 and held it in 3 quarters. The position peaked at $35.5K in Q1 2024. 56 funds tracked by Wall St. Rank hold LNAI as of Q4 2024.

  • Victory Capital Management reported no remaining Lunai Bioworks position as of Q4 2024 after selling out during the quarter.
  • Victory Capital Management sold 129 Lunai Bioworks shares in Q4 2024, an estimated $4.97K.
  • Victory Capital Management first reported a position in Lunai Bioworks in Q1 2024 and held it in 3 quarters.
  • Victory Capital Management's Lunai Bioworks position peaked at $35.5K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2024.

Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.